California Public Employees Retirement System Sells 5,966 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

California Public Employees Retirement System cut its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 0.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 849,307 shares of the company’s stock after selling 5,966 shares during the quarter. California Public Employees Retirement System owned 0.65% of Henry Schein worth $64,301,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of HSIC. Baystate Wealth Management LLC increased its stake in shares of Henry Schein by 2,500.0% in the 3rd quarter. Baystate Wealth Management LLC now owns 520 shares of the company’s stock valued at $39,000 after acquiring an additional 500 shares during the last quarter. McGlone Suttner Wealth Management Inc. bought a new stake in shares of Henry Schein in the 4th quarter valued at about $39,000. Neo Ivy Capital Management bought a new stake in shares of Henry Schein in the 3rd quarter valued at about $46,000. Covestor Ltd increased its stake in Henry Schein by 22.8% during the 3rd quarter. Covestor Ltd now owns 1,367 shares of the company’s stock worth $102,000 after purchasing an additional 254 shares in the last quarter. Finally, Fifth Third Bancorp increased its stake in Henry Schein by 14.3% during the 3rd quarter. Fifth Third Bancorp now owns 1,744 shares of the company’s stock worth $129,000 after purchasing an additional 218 shares in the last quarter. 96.62% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Jefferies Financial Group increased their target price on Henry Schein from $74.00 to $81.00 and gave the stock a “hold” rating in a research note on Wednesday, March 6th. Evercore ISI increased their target price on Henry Schein from $79.00 to $83.00 and gave the stock an “in-line” rating in a research note on Wednesday, February 28th. JPMorgan Chase & Co. increased their target price on Henry Schein from $82.00 to $88.00 and gave the stock an “overweight” rating in a research note on Wednesday, March 6th. SVB Leerink assumed coverage on Henry Schein in a research note on Monday, February 26th. They set a “market perform” rating and a $78.00 target price for the company. Finally, Leerink Partnrs reissued a “market perform” rating on shares of Henry Schein in a research note on Monday, February 26th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $81.09.

Insider Activity at Henry Schein

In other Henry Schein news, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction on Monday, March 18th. The shares were sold at an average price of $74.37, for a total transaction of $216,193.59. Following the completion of the transaction, the insider now directly owns 209,562 shares of the company’s stock, valued at $15,585,125.94. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other Henry Schein news, Vice Chairman James P. Breslawski sold 2,907 shares of Henry Schein stock in a transaction on Monday, March 18th. The shares were sold at an average price of $74.37, for a total transaction of $216,193.59. Following the completion of the transaction, the insider now directly owns 209,562 shares of the company’s stock, valued at $15,585,125.94. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the transaction, the chief executive officer now directly owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The disclosure for this sale can be found here. 1.14% of the stock is owned by company insiders.

Henry Schein Price Performance

NASDAQ:HSIC opened at $72.82 on Friday. Henry Schein, Inc. has a 1-year low of $60.01 and a 1-year high of $83.15. The company has a current ratio of 1.67, a quick ratio of 1.00 and a debt-to-equity ratio of 0.45. The firm has a fifty day simple moving average of $74.28 and a 200 day simple moving average of $72.43. The stock has a market capitalization of $9.36 billion, a PE ratio of 23.12, a P/E/G ratio of 1.81 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, February 27th. The company reported $0.66 earnings per share for the quarter, missing the consensus estimate of $0.70 by ($0.04). Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The firm had revenue of $3.02 billion during the quarter, compared to the consensus estimate of $3 billion. During the same period in the prior year, the business posted $1.21 earnings per share. Henry Schein’s quarterly revenue was down 10.5% compared to the same quarter last year. On average, research analysts expect that Henry Schein, Inc. will post 5.07 EPS for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.